Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

2 new

Companies in a sound financial shape with a dividend yield of more than 5%.

5 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.60

-0.2%

8.6%

Allied Biotech

Market Cap: NT$2.2b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$23.05

-1.5%

31.3%

TTY Biopharm

Market Cap: NT$19.2b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$77.30

0.9%

1.7%

Bioray Biotech

Market Cap: NT$605.0m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.

7561

NT$17.30

-34.0%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$74.70

3.3%

2.5%